| 1 |
Kim IR, Kim HC, Kook YB, Park SJ, Park YG, Park JH, et al. Boncho-Hak. Seoul:Young-Lim Press. 2007:203-4.
|
| 2 |
Lee WH. Effect of Phragmitis Rhizoma (PR) to Diabetes Mellitus of White Rat Induced by Streptozotocin. Kyung-san University Graduate School. 1983:1-33.
|
| 3 |
Kim YS. An Immunohistological Study of Effect of Phragmitis Rhizoma (PR) to Streptozotocin Diabetes J. East-West Medicines. 1993;18(3):30-9.
|
| 4 |
Choi JS, Chung HY, Young HS. A Preliminary Study on Hypocholesterolemic and Hypoglycemic Activities of Some Medicinal Plants. Kor. J. Pharmacogn. 1990;21(2):153-7
|
| 5 |
Choi JS, Lee JH, Han SY. Anti-hyperlipidemic Effect of Phragmitis communis and its Active Principles. J. Kor. Soc. Food Nutr. 1995;24(4):523-9
|
| 6 |
Jang KH, Roh SS. Depigementation activity of many herbs. Traditional Korean medicine questionnaires. 2004;13(2):289-302
|
| 7 |
Yoon JH. Whitening Activity of Phenolic Compound from Phragmitis Phizoma. Jung-ang University Graduate School. Pharmacy Pharmacognosy a master's thesis. 2006:1-79.
|
| 8 |
Gallin J, Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 3rd edition. Philadelphia:Lippincott William and Wilkins. 1999:1-4.
|
| 9 |
Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology. The immune system in Health and Disease. 4th edition. New York:Garland. 1999:1-30.
|
| 10 |
Roitt I, Brostoff J, Male D. Immunology. 5th edition. London:Mosby. 2002:264-5.
|
| 11 |
Available at: URL: http://en.wikipedia.org/wiki/Interleukin-6#cite_ref-2
|
| 12 |
Shute J, Vrugt B, Lindley I, Holgate S, Bron A, Aalbers R, et al. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Resp Crit Care Med. 1997;155:1877-83.
DOI
ScienceOn
|
| 13 |
Matsushima K, Larsen CGD, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocyte cell line. J Exp Med. 1998;169:1485-90.
|
| 14 |
Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein-1 acts as a T-lymphocyte. USA. Proc Natl Acad Sci. 1995;91:3652-56.
|
| 15 |
Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993;150:1932-43.
|
| 16 |
Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97:104-12.
DOI
|
| 17 |
Sousa AR, Lane S, Nakhostee JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol. 1994;10:142-47.
DOI
ScienceOn
|
| 18 |
Altman GB, Altman LC, Luchtel DL, Jabbour AJ, Baker C. Release of RANTES from nasal and bronchial epithelial cells. Cell Biology and Toxicology. 1997;13(3): 205-13.
DOI
ScienceOn
|
| 19 |
Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med. 1995;152:927-33.
DOI
|
| 20 |
Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol. 2003;112(4):83-8.
DOI
|
| 21 |
MacGlashan D Jr. Histamine: A mediator of inflammation. J Allergy Clin Immunol. 2003;112(4):53-9
DOI
|
| 22 |
Weltman JK. Histamine as a regulator of allergic and asthmatic inflammation. Allergy Asthma Proc. 2003;24(4):227-9.
|
| 23 |
Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003;112(1):15-22.
DOI
ScienceOn
|
webmaster
